Symbiotiq ApS: Financial statements 2024
CVR: 42741809
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Symbiotiq ApS (CVR 42741809) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,060,359 and a net result of DKK 585,824 compared with DKK 898,015 the year before. That is a decrease of 27.3% compared with the year before. Equity in the 2024 report amounted to DKK 1,924,510. The solvency ratio was 72%.
- Gross Profit
- DKK 1,060,359
- Profit/Loss
- DKK 585,824
- Equity
- DKK 1,924,510
- Total Assets
- DKK 2,671,852
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.1 mio. | 586 t. | 1.9 mio. | - |
| 2023 | - | 1.5 mio. | 898 t. | 1.5 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Symbiotiq ApS has published its annual report for 2023. Gross profit came to DKK 1,458,107, and the net result was DKK 898,015.
About Symbiotiq ApS
Symbiotiq ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mads Bonde. The company is owned by Mads Bonde. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,352,873 and a net result of DKK 288,354 compared with DKK 585,824 the year before. Equity in the 2025 report amounted to DKK 2,077,864.